000 01825cam  2200313zi 4500
0019.557874
003CaOODSP
00520210624172114
007cr |||||||||||
008150406s2001||||xxc|||||o    f|0| 0 eng d
020 |a0-88659-070-1
040 |aCaOODSP|beng
043 |an-cn---
0861 |aC89-4/85-2001E-PDF|zC89-4/85-2001E-IN
1001 |aBreau, Sébastien,|d1973- |eauthor.
24510|aProfile and prospects of the biopharmaceutical industry in Atlantic Canada / |cby Sébastien Breau.
260 |aMoncton, New Brunswick : |bAtlantic Canada Opportunities Agency, |c2001.
300 |a1 online resource (136 pages) : |bfigures, maps, references, tables.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aMaritime series. Monographs ;
5203 |a"The present monograph...explores in greater depth the integration of biotechnologies in the pharmaceutical industry and its economic impact in Atlantic Canada. This study is part of a shared project between the CIRRD and the Atlantic Canada Opportunities Agency (ACOA). It is exploratory in nature in that it investigates some of the principal developments taking place in the biopharmaceutical industry, emphasizing the industry's recent expansion in Atlantic Canada and its characteristics as well as examining various strategies to further promote its growth"--Foreword and methodology.
590 |a01-43|b2001-10-26
69007|aPharmaceutical industry|2gcpds
69007|aAtlantic provinces|2gcpds
7101 |aCanada. |bAtlantic Canada Opportunities Agency, |eissuing body.
830#0|aMaritime series. Monographs.|w(CaOODSP)9.504418
85640|ahttp://publications.gc.ca|qPDF|s2827 KB|uhttps://publications.gc.ca/collections/Collection/C89-4-85-2001E.pdf